PTJ
SRPT icon

Paul Tudor Jones’s Sarepta Therapeutics SRPT Stock Holding History

Paul Tudor Jones’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-152,803
Closed -$3.22M – 4027
2025
Q3 		$2.94M Buy
152,803
+101,952
+200% +$1.82M 0.01% 1545
2025
Q2 		$870K Buy
+50,851
New +$2.17M ﹤0.01% 2243
2024
Q1 		– Sell
-62,800
Closed -$6.06M – 2755
2023
Q4 		$6.06M Buy
+62,800
New +$6.02M 0.05% 543
2023
Q2 		– Sell
-14,561
Closed -$2.01M – 2897
2023
Q1 		$2.01M Sell
14,561
-15,851
-52% -$2.06M 0.03% 787
2022
Q4 		$3.94M Sell
30,412
-4,836
-14% -$560K 0.08% 324
2022
Q3 		$3.9M Buy
+35,248
New +$3.55M 0.08% 278
2022
Q2 		– Sell
-4,383
Closed -$342K – 2494
2022
Q1 		$342K Buy
4,383
+1,682
+62% +$129K 0.01% 1483
2021
Q4 		$243K Buy
+2,701
New +$231K ﹤0.01% 2007
2021
Q3 		– Sell
-56,657
Closed -$4.41M – 2782
2021
Q2 		$4.41M Buy
56,657
+50,173
+774% +$3.8M 0.08% 267
2021
Q1 		$483K Buy
6,484
+3,672
+131% +$339K 0.01% 1154
2020
Q4 		$479K Buy
+2,812
New +$417K 0.01% 968
2020
Q3 		– Sell
-14,034
Closed -$2.25M – 1529
2020
Q2 		$2.25M Buy
+14,034
New +$1.91M 0.11% 212
2018
Q3 		– Sell
-40,761
Closed -$5.39M – 1245
2018
Q2 		$5.39M Buy
+40,761
New +$3.84M 0.19% 61
2017
Q3 		– Sell
-27,517
Closed -$928K – 1243
2017
Q2 		$928K Sell
27,517
-53,412
-66% -$1.74M 0.03% 366
2017
Q1 		$2.4M Buy
+80,929
New +$2.5M 0.07% 165
2016
Q4 		– Sell
-215,933
Closed -$13.3M – 1596
2016
Q3 		$13.3M Buy
+215,933
New +$6.53M 0.31% 59
2015
Q4 		– Sell
-24,042
Closed -$772K – 1823
2015
Q3 		$772K Buy
+24,042
New +$816K 0.03% 512

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paul Tudor Jones's SRPT Position: Q4 2025 in Review

Paul Tudor Jones sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 152,803 shares — an estimated $3.22M sold.

Paul Tudor Jones first reported a position in SRPT in Q3 2015 and held it in 17 quarters. The position peaked at $13.3M in Q3 2016. 346 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Paul Tudor Jones reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Paul Tudor Jones sold 152,803 Sarepta Therapeutics shares in Q4 2025, an estimated $3.22M.
  • Paul Tudor Jones first reported a position in Sarepta Therapeutics in Q3 2015 and held it in 17 quarters.
  • Paul Tudor Jones's Sarepta Therapeutics position peaked at $13.3M in Q3 2016.
  • 346 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.